Cancer Research UK logo.
SearchDonate
  • Search

A study looking at rituximab, lenalidomide and ibrutinib for diffuse B cell lymphoma

Overview

Cancer types:

Blood cancers, Cell type, High grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)

Status:

Closed

Phase:

Phase 1/2

Details

It is for people with lymphoma that has come back or continued to grow after their first treatment. And who aren’t suitable for high dose chemotherapy and a stem cell transplant.

Recruitment start: 1 February 2014

Recruitment end: 30 September 2018

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Ardeshna

Supported by

Pharmacyclics LLC

Last reviewed: 30 September 2018

CRUK internal database number: 13810

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.